COLCHICINE : COVID-19 Trial Underway
Researchers in the United States, Canada & Europe are testing Colchicine on approximately 6,000 participants for a period of 30 days. The trial is to find out whether short-term treatment with colchicine will reduce lung complications and the rate of death in COVID-19 patients. Colchicine is thought to decrease the ‘cytokine storm’ or inflammation that…